{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:20:57Z","timestamp":1780579257625,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T23:33:03Z","timestamp":1491521583000},"page":"97-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Extended-release naltrexone for opioid use disorder started during or following incarceration"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4956-1226","authenticated-orcid":false,"given":"Thomas","family":"Lincoln","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jsat.2017.04.002_bb0005","first-page":"1249","article-title":"A public health model to connect correctional health care with communities","volume":"88","author":"Conklin","year":"1998","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2017.04.002_bb0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2014.09.002","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community","volume":"39","author":"Di Paola","year":"2014","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2017.04.002_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2016.06.003","article-title":"Injectable pharmacotherapy for opioid use disorders (IPOD)","volume":"49","author":"Farabee","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2017.04.002_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.002_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL(R) (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2017.04.002_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease","volume":"37","author":"Kinlock","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"13","key":"10.1016\/j.jsat.2017.04.002_bb0035","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2017.04.002_bb0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2017.04.002_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004479-200601000-00002","article-title":"Facilitators and barriers to continuing healthcare after jail: A community-integrated program","volume":"29","author":"Lincoln","year":"2006","journal-title":"Journal of Ambulatory Care Management"},{"issue":"3","key":"10.1016\/j.jsat.2017.04.002_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: Outcomes six months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2017.04.002_bb0055","author":"Massachusetts Department of Public Health"},{"key":"10.1016\/j.jsat.2017.04.002_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cct.2016.05.002","article-title":"Extended-release naltrexone opioid treatment at jail reentry (XOR)","volume":"49","author":"McDonald","year":"2016","journal-title":"Contemporary Clinical Trials"},{"issue":"9","key":"10.1016\/j.jsat.2017.04.002_bb0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"issue":"3","key":"10.1016\/j.jsat.2017.04.002_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jurban\/jti072","article-title":"Attitudes and practices regarding the use of methadone in US state and Federal Prisons","volume":"82","author":"Rich","year":"2005","journal-title":"Journal of Urban Health"},{"issue":"9991","key":"10.1016\/j.jsat.2017.04.002_bb0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2017.04.002_bb0080","first-page":"27","article-title":"Pharmacotherapy for opioid dependence in jails and prisons: Research review update and future directions. [review]","volume":"7","author":"Sharma","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.jsat.2017.04.002_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2015.10.023","article-title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","volume":"157","author":"Springer","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.002_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2016.01.007","article-title":"Linkage to primary care for persons first receiving injectable naltrexone during inpatient opioid detoxification","volume":"64","author":"Stein","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.04.002_bb0095","series-title":"Results from the 2012 national survey on drug use and health: summary of national findings. NSDUH series H-46, HHS publication no. (SMA) 13-4795","author":"Substance Abuse and Mental Health Services Administration","year":"2013"},{"issue":"2","key":"10.1016\/j.jsat.2017.04.002_bb0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release. [Research support, N.I.H., extramural]","volume":"45","author":"Zaller","year":"2013","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216305013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216305013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:36Z","timestamp":1760039256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216305013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"alternative-id":["S0740547216305013"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.04.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-release naltrexone for opioid use disorder started during or following incarceration","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}